Makers Labs.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE987A01010
NSEID:
BSEID: 506919

INR

134.00

0.00 (0.00%)

BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 871

{
  "main_header": {
    "sid": 878419,
    "name": "Makers Labs.",
    "stock_name": "Makers Labs.",
    "full_name": "Makers Laboratories Ltd",
    "name_url": "stocks-analysis/makers-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "134.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "134.00",
    "mcapval": "79.07 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506919,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE987A01010",
    "curr_date": "Apr 11, 12:52 PM",
    "curr_time": "23:44 PM",
    "bse_nse_vol": "871 ",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/makers-labs-878419-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Makers Laboratories Faces Evaluation Shift Amid Mixed Financial Performance and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-stock-downgraded-to-strong-sell-amid-bearish-technical-indicators-1619703",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/MakersLaborator_mojoScore_815194.png",
        "date": "2025-03-27 08:04:02",
        "description": "Makers Laboratories has recently experienced a change in its evaluation, reflecting a shift in technical trends. While the company reported positive quarterly financial results, challenges persist, including declining operating profit growth and low return on equity. The adjustment highlights the need to monitor both technical and fundamental factors."
      },
      {
        "title": "Makers Laboratories Faces Mixed Performance Amid Market Volatility and Technical Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-reports-15-21-annual-growth-despite-recent-stock-decline-1612585",
        "imagepath": "",
        "date": "2025-03-26 18:00:18",
        "description": "Makers Laboratories, a microcap player in the Pharmaceuticals & Drugs industry, has experienced notable stock activity today. The company, with a market capitalization of Rs 82.00 crore, currently holds a price-to-earnings (P/E) ratio of 11.41, significantly lower than the industry average of 37.74. \n\nOver the past year, Makers Laboratories has shown a performance increase of 15.21%, outperforming the Sensex, which rose by 6.65%. However, recent trends indicate a decline, with the stock down 1.81% today, compared to a 0.93% drop in the Sensex. The stock has also faced challenges over the past month, declining by 9.03%, while the Sensex gained 3.60%.\n\nLonger-term performance metrics reveal a mixed picture. Year-to-date, the stock is down 24.88%, contrasting with the Sensex's modest decline of 1.09%. Over three years, Makers Laboratories has decreased by 26.80%, while the Sensex has risen by 34.74%. In the fi..."
      },
      {
        "title": "Makers Laboratories Reports Q3 FY24-25 Profit Growth Amid Long-Term Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-downgraded-to-sell-despite-positive-q3-fy24-25-financial-performance-963002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MakersLaborator_mojoScore_410299.png",
        "date": "2025-02-11 19:00:41",
        "description": "Makers Laboratories, a microcap in the Pharmaceuticals & Drugs sector, recently experienced a score adjustment reflecting its financial metrics and market position. The company reported a profit after tax of Rs 8.41 crore in Q3 FY24-25, showcasing strong short-term performance despite long-term challenges in operating profits and return on equity."
      },
      {
        "title": "Makers Laboratories Reports Mixed Financial Results for December Quarter, Highlights Operational Strengths and Profitability Challenges",
        "link": "https://www.marketsmojo.com/news/result-analysis/makers-laboratories-reports-q3-fy-2024-25-results-with-decline-in-profit-after-tax-397704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/MakersLaborator_quaterlyResult_283339.png",
        "date": "2025-01-29 17:33:56",
        "description": "Makers Laboratories has released its financial results for the quarter ending December 2024, showing a mixed performance. While the Debtors Turnover Ratio reached a five-period high, the Profit After Tax reported a notable decline, indicating challenges in profitability despite some operational strengths."
      }
    ],
    "total": 20,
    "sid": "878419",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/makers-laboratories-878419"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "Compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Jan-2025",
      "details": "Copy of Newspaper Publication",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Makers Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 01 Aug 19",
          "dt": "2019-08-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Makers Laboratories Ltd has announced <strong>1:5</strong> rights issue, ex-date: 30 Mar 22",
          "dt": "2022-03-30",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Makers Laboratories Faces Evaluation Shift Amid Mixed Financial Performance and Technical Signals

2025-03-27 08:04:02

Makers Laboratories has recently experienced a change in its evaluation, reflecting a shift in technical trends. While the company reported positive quarterly financial results, challenges persist, including declining operating profit growth and low return on equity. The adjustment highlights the need to monitor both technical and fundamental factors.

Makers Laboratories Faces Mixed Performance Amid Market Volatility and Technical Challenges

2025-03-26 18:00:18

Makers Laboratories, a microcap player in the Pharmaceuticals & Drugs industry, has experienced notable stock activity today. The company, with a market capitalization of Rs 82.00 crore, currently holds a price-to-earnings (P/E) ratio of 11.41, significantly lower than the industry average of 37.74. Over the past year, Makers Laboratories has shown a performance increase of 15.21%, outperforming the Sensex, which rose by 6.65%. However, recent trends indicate a decline, with the stock down 1.81% today, compared to a 0.93% drop in the Sensex. The stock has also faced challenges over the past month, declining by 9.03%, while the Sensex gained 3.60%. Longer-term performance metrics reveal a mixed picture. Year-to-date, the stock is down 24.88%, contrasting with the Sensex's modest decline of 1.09%. Over three years, Makers Laboratories has decreased by 26.80%, while the Sensex has risen by 34.74%. In the fi...

Makers Laboratories Reports Q3 FY24-25 Profit Growth Amid Long-Term Challenges

2025-02-11 19:00:41

Makers Laboratories, a microcap in the Pharmaceuticals & Drugs sector, recently experienced a score adjustment reflecting its financial metrics and market position. The company reported a profit after tax of Rs 8.41 crore in Q3 FY24-25, showcasing strong short-term performance despite long-term challenges in operating profits and return on equity.

Makers Laboratories Reports Mixed Financial Results for December Quarter, Highlights Operational Strengths and Profitability Challenges

2025-01-29 17:33:56

Makers Laboratories has released its financial results for the quarter ending December 2024, showing a mixed performance. While the Debtors Turnover Ratio reached a five-period high, the Profit After Tax reported a notable decline, indicating challenges in profitability despite some operational strengths.